# Bristol-Myers Squibb Company (BMY) — Q4-2011 Earnings Results

**Report date:** 2012-01-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2011

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 0.67%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.63 | N/A | +14.34% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They noted the importance of their product portfolio in driving future growth.

**Key quotes:**

> Management highlighted the strong performance of key products.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock declined slightly by 0.67% following the announcement, which may reflect investor caution due to the lack of revenue data and guidance. The management's focus on product performance and innovation suggests a commitment to long-term growth despite the immediate stock reaction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2011_